ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,285
0,00%
Bitcoin
98 378,00
-0,31%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Sunshine Biopharma Inc (SBFM) Cours

Sunshine Biopharma Inc

Sunshine Biopharma Inc (SBFM)

NASDAQ
3,24
0,24
(8,00%)
À la fermeture: 25 Décembre 10:00PM
Retardé de 15 minutes
3,24
-0,12
( -3,70% )
Après les heures de négociation: 10:59PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
3,24
Prix Achat
3,12
Prix Vente
3,15
Volume échangé
162 615
2,93 Fourchette du Jour 3,26
2,1056 Plage de 52 semaines 608,00
Cap du marché
6,479M
Clôture Veille
3,00
Ouverture
2,98
Dernière Transaction
1
@
3.1206
Dernière heure de transaction
Volume financier
US$ 511 709
VWAP
3,1468
Volume moyen (3 m)
1 141 237
Actions en circulation
1 999 660
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,44
Bénéfice par action (BPA)
-2,25
Chiffre d'affairess
24,09M
Bénéfice net
-4,51M

À propos de Sunshine Biopharma Inc

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.sunshinebiopharma.com
Siège social
Montreal, Quebec, Can
Fondé
-
Sunshine Biopharma Inc est coté dans le secteur Coml Physical, Biologcl Resh de la NASDAQ avec le ticker SBFM. Le dernier cours de clôture d'Sunshine Biopharma était de US$3,00. Au cours de la dernière année, les actions de Sunshine Biopharma ont été négociées dans une fourchette de prix de US$ 2,1056 à US$ 608,00.

Sunshine Biopharma compte actuellement 1 999 660 actions en circulation. La capitalisation boursière d'Sunshine Biopharma est de US$6,00 million. Sunshine Biopharma a un ratio cours/bénéfice (ratio PE) de -1.44.

SBFM Dernières nouvelles

Plus de nouvelles

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

20 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Août 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 Août 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

14 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Août 2024
Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements

11 Juillet 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 Mars 2024
Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements

05 Mars 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Mars 2024
Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

23 Février 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.5922.26415094342.653.242.511619492.8119072CS
40.8636.13445378152.383.47992.385042273.02100093CS
120.123.846153846153.123.47992.105611412372.48154271CS
26-3.17-49.45397815916.419.362.10569421803.92991356CS
52-516.76-99.37692307695206082.10567383892138.01189505CS
156-5496.76-99.94109090915500197402.105639098553085.11892789CS
260-5496.76-99.94109090915500197402.105639098553085.11892789CS

SBFM - Frequently Asked Questions (FAQ)

What is the current Sunshine Biopharma share price?
The current share price of Sunshine Biopharma is US$ 3,24
How many Sunshine Biopharma shares are in issue?
Sunshine Biopharma has 1 999 660 shares in issue
What is the market cap of Sunshine Biopharma?
The market capitalisation of Sunshine Biopharma is USD 6M
What is the 1 year trading range for Sunshine Biopharma share price?
Sunshine Biopharma has traded in the range of US$ 2,1056 to US$ 608,00 during the past year
What is the PE ratio of Sunshine Biopharma?
The price to earnings ratio of Sunshine Biopharma is -1,44
What is the cash to sales ratio of Sunshine Biopharma?
The cash to sales ratio of Sunshine Biopharma is 0,27
What is the reporting currency for Sunshine Biopharma?
Sunshine Biopharma reports financial results in USD
What is the latest annual turnover for Sunshine Biopharma?
The latest annual turnover of Sunshine Biopharma is USD 24,09M
What is the latest annual profit for Sunshine Biopharma?
The latest annual profit of Sunshine Biopharma is USD -4,51M
What is the registered address of Sunshine Biopharma?
The registered address for Sunshine Biopharma is 6500 TRANS-CANADA HIGHWAY 4TH FLOOR, POINTE-CLAIRE, QUEBEC, MONTREAL, QUEBEC, H9R 0A5
What is the Sunshine Biopharma website address?
The website address for Sunshine Biopharma is www.sunshinebiopharma.com
Which industry sector does Sunshine Biopharma operate in?
Sunshine Biopharma operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7,10
(310,40%)
58,74M
HOURHour Loop Inc
US$ 4,40
(207,69%)
97,42M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
CREVCarbon Revolution Public Ltd
US$ 9,16
(135,48%)
26,95M
AVGRAvinger Inc
US$ 1,45
(125,72%)
107,53M
SLGLSol Gel Technologies Ltd
US$ 0,9798
(-40,62%)
3,07M
DRCTDirect Digital Holdings Inc
US$ 3,71
(-32,55%)
23,82M
CHEKCheck Cap Ltd
US$ 1,55
(-31,11%)
3,49M
SYTASiyata Mobile Inc
US$ 0,5178
(-30,83%)
2,63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15,47
(-30,38%)
147,98k
SVMHSRIVARU Holding Ltd
US$ 0,0338
(20,71%)
280,27M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
LITMSnow Lake Resources Ltd
US$ 0,5849
(52,84%)
181,22M
LCIDLucid Group Inc
US$ 3,20
(3,23%)
108,75M
RGTIRigetti Computing Inc
US$ 11,35
(3,56%)
108,38M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SBFM
Sunshine Biopharma
LSE
PM80
Natwest.m 29
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés